Social and Policy Implications of Low-Level Exposures to Chemicals by Ashford, Nicholas A. & Miller, Claudia S.
SOCIAL AND POLICY IMPLICATIONS
OF LOW-LEVEL EXPOSURES TO CHEMICALS1
Nicholas A. Ashford and Claudia S. Miller
The Problem
There is mounting evidence that human exposure to chemicals at levels once thought to
be safe (or presenting insignificant risk) could be harmful.  So-called low-level
exposures have been linked with adverse biological effects including endocrine
disruption (1), chemical sensitivity (2), and cancer (3).  In the 16th century, Paracelsus
observed that the dose makes the poison.  A more apt and modern revision might be
that the host plus the dose makes the poison.  Prior susceptibility of the host, whether
inborn or environmentally induced, followed by other lifetime exposures, can cause
irreversible injury.   Humans in their most vulnerable developmental state, whether in
the womb or during infancy, warrant special consideration, both in their own right and as
sentinel indicators.   The emerging science associated with low-level chemical
exposures requires that we change both (1) the way we think about chemicals and
health, including the adequacy of quantitative risk assessment, and (2) the solutions we
devise to prevent and address chemically-caused injury.
Chemicals and Health
In his seminal work, The Structure of Scientific Revolutions, Thomas Kuhn described
the process by which scientific knowledge evolves (4).  His general observations are
adapted here specifically to address the issue of emerging theories of disease (Table
1).  New theories emerge only after much difficulty.   At this point in time, we are just
beginning to recognize the link between chemicals and a host of new public health
problems that challenge the tenets of traditional toxicology and medicine.  These include
birth defects (and other damage) due to developmental toxicants; auto-immune
diseases, including lupus, scleroderma, and Sjøgren's Syndrome; certain chronic
conditions in children such as attention deficit hyperactivity disorder, depression, and
asthma that have become more prevalent in the past few decades; chemical sensitivity
including its overlaps with sick building syndrome, the unexplained illnesses of Gulf War
veterans, chronic fatigue syndrome, fibromyalgia, and toxic encephalopathy; and,
finally, new links to cancer, including childhood cancers.
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These emerging public health problems are characterized by six common threads which
provide a new perspective on disease: (1) They represent a departure from many
classic diseases such as tuberculosis and heart disease in that communication systems
or networks, rather than specific organs of the body appear to be the target.  These
include the endocrine system, the immune system, and the neurological system; (2) No
single cause has been identified for each of these conditions.   Further, there are often
no clear biomarkers for either exposure or disease.  Because of the current lack of clear
biomarkers, classical epidemiology is less able to identify susceptible or sensitive
subgroups; (3) Disease becomes manifest after two or more stages or events occur. 
For example, some cancer (and of course cancer is not a single disease) may proceed
first by initiation -- a mutation that alters the genetic material of the cell -- followed by the
promotion of cancer cells to a recognizable tumor.  These two stages can involve
different chemicals, radiation, or viruses.  It has been hypothesized that Toxicant-
induced Loss of Tolerance (TILT) leading to chemical sensitivity also proceeds via a
two-stage process: (a) an initial exposure to high levels of certain chemicals (or
repeated exposures at lower levels), followed by (b) triggering of symptoms by everyday
chemical exposures at levels that do not appear to affect most people (2); (4) The  time
between the first and subsequent stages of disease can be long enough to obscure the
connection between exposures and ultimate disease.  The latency of chemically-caused
cancer is measured in years.  Observable reproductive system failure after endocrine
disruption can occur years later.  Furthermore, the timing of the initial exposure can be
crucial because there are crucial periods in the developmental process that are
especially susceptible to damage.  Chemical sensitivity reportedly can develop months
after the initial exposure and remain manifest for years.  Furthermore, the timing of the
initiating doses appears important.  Loss of tolerance does not always require a high
initial dose; smaller doses, strategically timed, might also cause pathological loss of
tolerance; (5) The classical approaches and models used in both toxicology and
epidemiology, premised on single agents disrupting individual organs, do not explain
these diseases.  Moreover, the relationship between the initiating exposure and ultimate
health effects/disease (the dose-effect/response curve) is not monotonic--i.e., the extent
of disease does not increase in a regular way as a function of dose.  We have seen this
vividly in the recent work of Fred vom Saal on the endocrine-disrupting effects of bis-
phenol A (5); and (6) Endocrine disruption (ED), TILT, and some cancers appear to
represent a failure in functional and/or adaptive processes in important systems or
networks as a result of chemical exposures at concentrations three to six orders of
magnitude lower than those associated with classical toxic effects in normal individuals.
 Today, individuals may be exposed to multiple xenobiotics simultaneously, as in a sick
building in which hundreds of volatile organic compounds might be present in the air.
Endocrine disruption (ED), TILT, and some cancers may be inter-related.  ED disrupts 
normal development, and possibly the immune system, resulting in increased
susceptibility to certain cancers.  ED might also affect the neurological system, leading
to increased susceptibility to sensitization by chemicals.  TILT manifests as a loss of
tolerance to everyday chemical, food, and drug exposures in affected persons, possibly
leaving these individuals more susceptible to other disease.  TILT may, in fact,
represent a new theory of disease (2) .  Just as the general category of "infectious
diseases" encompasses a diverse spectrum of diseases involving different organisms
(which affect different organs via different specific disease mechanisms), TILT may
arise from different chemical exposures (which, like the infectious diseases, could affect
different organ systems via different specific disease mechanisms).  With Toxicant-
Induced Loss of Tolerance, key systems of the body appear to lose their ability to adapt
to low-level chemical exposures.  Finally, cancer proceeds when adaptive, homeostatic
repair processes and the immune system no longer function as they should.  The cause
of the loss of protective function is not well understood.
Public Policy Responses
We have proposed that a systems-focused approach to disease best fits the pattern of
these emerging illnesses of the 21st Century.  It is our view that a systems approach
likewise is needed as we fashion our public policy responses.  The lack of clear
biomarkers and the time lag between initiating exposures and ultimate disease make it
technically, and increasingly politically, difficult to develop the extensive body of
evidence needed to regulate many  chemicals and industrial processes or to
compensate the chemically injured. For this reason, we must seriously consider
adoption of the Precautionary Principle, a concept endorsed at the UN Conference on 
Environment and Sustainable Development in Rio de Janeiro and already implemented
in some European and U.S. regulatory systems. That is, we must act preventively in the
face of uncertainty, erring on the side of caution.  This requires education of the public,
government, and industry, as well as political courage and conviction.
Over the past 25 years, scientific concern over emerging environmental or public health
 problems generally has begun with a suggestion -- sometimes a mere whisper -- that
trouble was brewing.  Those suggestions and whispers ultimately ripened into full-
fledged confirmations that our worst fears were true.  Examples include asbestos-
related cancer, and the toxic effects of benzene, lead, and persistent pesticides.  The
frightening but enlightening reality is that with few exceptions the early warnings
warranted heeding and the bulk of predictions were certainly in the right direction, if not
understated.  In retrospect, not only  were our precautionary actions justified, but we
waited far too long to take those actions.  Endocrine disrupting chemicals present an
opportunity to act more quickly than we have in the past, although some damage has
already been done.  Intervening now to prevent the next generation of developmentally
or immunologically compromised or chemically intolerant persons, many of them
children, is both possible and necessary.
Admittedly, there is considerable uncertainty about some aspects of endocrine
disruption and other systemic damage or injury.  We are told that this uncertainty places
environmental legislators and regulators on the horns of a dilemma.  They must risk
making one of two types of mistakes: a Type I error is committed if they fail to regulate a
chemical which turns out later to be harmful; a Type II error is committed if they regulate
a chemical, imposing large costs on industry and the consumer, and the chemical later
turns out to be safe.  The Precautionary Principle argues for regulation when the
scientific evidence is sufficiently compelling--but not perfect.  It states a preference for
avoiding a Type I error.  As long as there is some scientific uncertainty, even if it is
small, a potentially regulated industry is understandably more interested in avoiding a
Type II error.
For the major stakeholders, these public policy responses suggest specific challenges. 
For industry it means a new kind of corporate stewardship that is in harmony with their
customers' and the public's expectations that they will adhere to the Precautionary
Principle,  including the continuous seeking of less toxic, more sustainable technology to
replace the old.  For government it means a return to its role as a trustee of the
environment, public health, and sustainability -- rather than serving as an arbiter or
mediator of conflicts among the stakeholders.  Further, government needs to address its
interventions to all the stages of multi-stage disease, for example to promoters as well
as initiators of cancer.  For  the media it means an increased commitment to 
understanding, reporting, and educating the public about the truth -- the complex truth--
which takes more than a sixty-second sound-bite or a 3-inch column.  For the public
interest/non-governmental organizations it means coalition-building and agendas that
involve disparate groups, such as parents concerned with birth defects, advocates for
toxic-free schools, and unions concerned with occupational exposures.  For the
international community it means a commitment to research and to multilateral
environmental agreements, such as the proposal to ban Persistent Organic Pollutants
(POPs).  It will be important to ensure that such future agreements do not result in
banning endocrine disrupting chemicals only to substitute chemicals with some other
kind of harmful effect, or putting workers at significant risk in order to protect the general
public.  To win international approval, the strategy for EDs and other harmful chemicals
must be one that ensures that less-developed nations have access to superior
technology so that they can "leap-frog" into sustainable development.  This is yet
another reason to ensure that policies for science, technology, and regulation are
coordinated.  Finally, for private philanthropy it means greatly increased support for
independent science, advocacy efforts for the environment, and education of the public.
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STAGES OF A PARADIGM SHIFT
(After Kuhn)
M  Ignore Departures From the Existing Paradigm
M  Deny That an Anomaly Exists;  Blame It On Faulty Observation
Or Testing Error; Deride the Proponents of the New Paradigm
M  Acknowledge the Anomaly, But Call It "Idiopathic"
M  Try To Explain the Anomaly With The Existing Paradigm,
Sometimes By Making Minor Adjustments.
M  Seek Alternative Paradigms To Contradict or Minimize The One
Proposed.
M  Recognize Paradigm As Valid, But Within A Narrow Context
Relegated To "Exceptions"
M  Accept the New Paradigm As Offering Some Explanatory Power,
But Retain the Old Paradigm, Too
M  Discredit the Old Paradigm; Deride Any Attempt To Reinstate Or
Rehabilitate Old Paradigm
M  Accept New Paradigm With Enthusiasm
M  Begin Again
Source: Ashford & Miller Chemical Exposures: Low Levels and High
Stakes, John Wiley Press, 1998.
